Emerging Technology Partners is a life sciences focused investment firm.
Founded in 2000, Emerging Technology Partners (“ETP”) is a life sciences focused investment fund with a cross border investment focus. ETP was founded with a simple mission: to provide capital and assist management in building and commercializing breakthrough diagnostic and therapeutic products in the fields of life sciences, while providing superior returns to their investors.ETP supports their portfolio companies facilitate strategic alliances including cross-border partnerships, recruit management, and acquire new products and technologies to accelerate growth in both US and China. They have investment partners in San Francisco, Boston, Washington DC, and Beijing.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
May 1, 2020
SleepScore Labs
|
Series Unknown | — | Fitness | Yes |
May 3, 2006
Alaunos Therapeutics
|
Post-IPO Equity | $37M | Biotechnology | — |
Oct 19, 2005
HTG Molecular Diagnostics
|
Series B | $3.40M | Biotechnology | — |